Copyright
©The Author(s) 2017.
World J Gastroenterol. Dec 14, 2017; 23(46): 8120-8127
Published online Dec 14, 2017. doi: 10.3748/wjg.v23.i46.8120
Published online Dec 14, 2017. doi: 10.3748/wjg.v23.i46.8120
Table 2 Resistance-associated substitutions or treatment-emergent substitutions of hepatitis C virus NS5B nucleos(t)ide inhibitors
Domains of HCV NS5B polymerase[45] | HCV genotypes (GTs) | Ref. | ||
GT1 | GT1a | GT1b | ||
Fingers domain (AA1-188, 226-287) | C14R | [40] | ||
D61G | [40] | |||
T77T/A | [41] | |||
S96T | [42] | |||
N142T | N142S | [40,42] | ||
L159F | [40-44] | |||
E237G | [40] | |||
S282T | S282R | [40-42] | ||
Palm domain (AA188-226, 287-371) | M289I/L | [42,44] | ||
L314P | [40] | |||
C316R | [41] | |||
L320F | L320I/V | [40-42] | ||
V321A | V321I | [40,42,43] | ||
T344I | [40] | |||
Thumb domain (AA371-530) | F415Y | [43] | ||
E440G, E/G | [42] | |||
S470G | [40] |
- Citation: Kanda T, Nirei K, Matsumoto N, Higuchi T, Nakamura H, Yamagami H, Matsuoka S, Moriyama M. Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b. World J Gastroenterol 2017; 23(46): 8120-8127
- URL: https://www.wjgnet.com/1007-9327/full/v23/i46/8120.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i46.8120